Children’s Hospital investigators may have developed a completely new type of cancer immunotherapy, one that involves harnessing the body’s immune system to attack tumors.
A neonatologist at CHOP led a new study showing current non-invasive techniques for respiratory support are less effective than previously thought in reducing severe lung injury in very premature infants.
There is convincing evidence that individuals – including teens – with attention deficit hyperactivity disorder (ADHD) are at heightened risk for unsafe driving behaviors.
Researchers from The Children’s Hospital of Philadelphia and the University of Pennsylvania recently published a study in the Journal of the American Medical Association (JAMA) that shows differences in how breast cancer patients present at diagnosis are more responsible for racial disparities in 5-year survival than treatment disparities.
Monrovia, Calif.-based St. Baldrick’s Foundation recently announced $699,186 in grants to one consortium and three cancer researchers at CHOP.
A pediatric cardiologist at The Children’s Hospital of Philadelphia is a first author of new research identifying a mutation that disrupts the formation of veins bringing blood to the heart very early in development.
In two new studies, investigators from CHOP reprogrammed skin cells from patients with rare disorders into induced pluripotent stem cells (iPSCs).
Signed into law by President Obama in March 2010, the Patient Protection and Affordable Care Act — popularly known as “Obamacare” — contains a number of provisions designed to expand health insurance coverage.
Children’s Hospital researchers recently identified a network of signaling molecules that acts like a “fuse box,” regulating the effects of defective energy flow in mitochondrial respiratory chain diseases.
Gene therapy researchers at The Children’s Hospital of Philadelphia have produced a bioengineered decoy that by fooling the immune system prevents it from undermining the benefits delivered by a corrective gene.